吲哚拉明对运动诱发哮喘的预防作用。
Prevention of exercise-induced asthma by indoramin.
作者信息
Bianco S, Griffin J P, Kamburoff P L, Prime F J
出版信息
Br Med J. 1974 Oct 5;4(5935):18-20. doi: 10.1136/bmj.4.5935.18.
Abstract
Indoramin, an alpha-adrenoceptor blocking drug, has been found to prevent the occurrence of exercise-induced bronchoconstriction. Evidence is provided in two cases that this was not due to the antihistamine properties of indoramin.
摘要
吲哚拉明是一种α-肾上腺素能受体阻断药，已发现它能预防运动诱发的支气管收缩。两个病例提供的证据表明，这并非归因于吲哚拉明的抗组胺特性。
相似文献
1
Prevention of exercise-induced asthma by indoramin.吲哚拉明对运动诱发哮喘的预防作用。
Br Med J. 1974 Oct 5;4(5935):18-20. doi: 10.1136/bmj.4.5935.18.
2
Letter: Prevention of exercise-induced asthma by indoramin.信函：吲哚拉明预防运动诱发性哮喘
Br Med J. 1974 Dec 28;4(5947):770-1. doi: 10.1136/bmj.4.5947.770-a.
3
Letter: Prevention of exercise-induced asthma by indoramin.信函：吲哚拉明对运动诱发性哮喘的预防作用
Br Med J. 1974 Nov 23;4(5942):469. doi: 10.1136/bmj.4.5942.469.
4
The treatment of arterial hypertension with a new alpha-blocker, indoramin.
Curr Med Res Opin. 1974;2(8):437-43. doi: 10.1185/03007997409115239.
5
[Drug prevention of bronchial asthma: inhibition of histamine and exercise-induced asthma by a new anti-anaphylactic oral preparation (ketotifen) (author's transl)].[药物预防支气管哮喘：一种新型抗变态反应口服制剂（酮替芬）对组胺和运动诱发哮喘的抑制作用（作者译）]
Dtsch Med Wochenschr. 1978 Nov 24;103(47):1865-9. doi: 10.1055/s-0028-1129358.
6
A trial of an alpha-adrenoreceptor blocking drug (indoramin) in exercise-induced bronchoconstriction.
Scand J Respir Dis. 1976;57(6):261-6.
7
Alpha-adrenoreceptor blockade with indoramin in hypertension.吲哚拉明对高血压患者的α-肾上腺素能受体阻滞作用
J Cardiovasc Pharmacol. 1983 May-Jun;5(3):343-8. doi: 10.1097/00005344-198305000-00001.
8
Further observations on the experimental antidysrhythmic activity of indoramin hydrochloride.关于盐酸吲哚拉明实验性抗心律失常活性的进一步观察
J Pharm Pharmacol. 1973 Sep;25(9):700-4. doi: 10.1111/j.2042-7158.1973.tb10050.x.
9
Proceedings: Alpha-adrenoceptor inhibition from indoramin in man.论文集：吲哚拉明对人体α-肾上腺素能受体的抑制作用
Br J Pharmacol. 1972 Feb;44(2):378P-379P.
10
Alpha-adrenergic blockade in severe asthma.
Br J Dis Chest. 1979 Jul;73(3):317-8.
引用本文的文献
1
Clinical pharmacokinetics of vasodilators. Part II.血管扩张剂的临床药代动力学。第二部分。
Clin Pharmacokinet. 1998 Jul;35(1):9-36. doi: 10.2165/00003088-199835010-00002.
2
Plasma catecholamines during exercise-induced bronchoconstriction in bronchial asthma.支气管哮喘患者运动诱发支气管收缩期间的血浆儿茶酚胺
Thorax. 1980 Nov;35(11):823-7. doi: 10.1136/thx.35.11.823.
3
The effects of indoramin on histamine and antigen-induced changes in respiration in guinea-pigs.吲哚拉明对组胺和抗原诱导的豚鼠呼吸变化的影响。
Agents Actions. 1980 Nov;10(5):399-402. doi: 10.1007/BF01968036.
4
Failure of ejaculation with indoramin.因使用吲哚拉明导致射精障碍。
Br Med J (Clin Res Ed). 1981 May 2;282(6274):1433-4. doi: 10.1136/bmj.282.6274.1433-a.
5
Inhaled prazosin in asthma.哮喘患者吸入哌唑嗪
Thorax. 1981 May;36(5):378-81. doi: 10.1136/thx.36.5.378.
6
Bronchial asthma in adults: presentation to the emergency department. Part I: Pathogenesis, clinical manifestations, diagnostic evaluation, and differential diagnosis.成人支气管哮喘：急诊科就诊情况。第一部分：发病机制、临床表现、诊断评估及鉴别诊断。
Am J Emerg Med. 1983 Jul;1(1):50-70. doi: 10.1016/0735-6757(83)90038-4.
7
The management of hypertension.高血压的管理
Br J Clin Pharmacol. 1986;21 Suppl 2(Suppl 2):129S-142S. doi: 10.1111/j.1365-2125.1986.tb02862.x.
8
Indoramin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and related vascular, cardiovascular and airway diseases.吲哚拉明。对其药效学和药代动力学特性以及在高血压及相关血管、心血管和气道疾病中的治疗效果的综述。
Drugs. 1986 Jun;31(6):467-99. doi: 10.2165/00003495-198631060-00002.
9
Prazosin in the treatment of chronic asthma.哌唑嗪治疗慢性哮喘
Thorax. 1988 May;43(5):385-7. doi: 10.1136/thx.43.5.385.
10
Failure of enhancement by labetalol of bronchopulmonary effects of histamine in guinea-pigs: independence of alpha-adrenoceptor antagonism.拉贝洛尔未能增强组胺对豚鼠支气管肺的效应：α-肾上腺素能受体拮抗作用的独立性。
Br J Pharmacol. 1987 Jul;91(3):487-92. doi: 10.1111/j.1476-5381.1987.tb11241.x.
本文引用的文献
1
Changes in plasma concentration of epinephrine and norepinephrine with muscular work.
Proc Soc Exp Biol Med. 1957 Dec;96(3):636-8. doi: 10.3181/00379727-96-23561.
2
Pharmacologic studies of indoramin in man.
Clin Pharmacol Ther. 1972 May-Jun;13(3):380-92. doi: 10.1002/cpt1972133380.
3
Competitive blockade of adrenergic alpha-receptors and histamine receptors by thymoxamine.
J Pharm Pharmacol. 1965 Jul;17(7):449-58. doi: 10.1111/j.2042-7158.1965.tb07701.x.
4
Clinical evaluation of indoramin, a new antihypertensive agent.
Eur J Clin Pharmacol. 1973 Dec;6(4):211-6. doi: 10.1007/BF00644733.
Zotero 插件